Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo

The cell surface glycoprotein CD44 is expressed in cancer cells and has been used as a therapeutic target in preclinical studies. However, the ubiquitous expression of CD44 in numerous cell types, including hematopoietic cells, has hindered its application in targeted therapy. Here, we demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Cuixia, He, Yiqing, Zhang, Huizhen, Liu, Yiwen, Wang, Wenjuan, Du, Yan, Gao, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558151/
https://www.ncbi.nlm.nih.gov/pubmed/25909172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558151/
https://www.ncbi.nlm.nih.gov/pubmed/25909172

Ejemplares similares